Navigation Links
Life Sciences Company Sword Diagnostics Moves Operations to Chicago
Date:4/26/2010

University Technology Park at IIT Continues 2010 Growth

Chicago, IL (Vocus) April 26, 2010 -- Sword Diagnostics, Inc., committed to improving healthcare through the use of innovative detection technology, today announced the relocation of its corporate headquarters and research facilities to accommodate planned growth. Double the size of its current space in the suburbs, Sword’s new location at University Technology Park at IIT (UTP) in Chicago marks its shift from start-up venture to growth-stage commercial entity.

Sword launched its proprietary biological detection system in January 2010, closely following the issuance of the company’s core patent. Developed for ultra-sensitive immunoassays, the technology allows greater sensitivity and improved accuracy in disease marker testing, without increasing cost or complexity. Such performance enhancements accelerate gains in basic and clinical research, drug discovery, and clinical diagnostics development, leading to advancements in disease detection.

"This is an important milestone for our company,” said Sword Diagnostics President Dave Dingott. "Our new facility at UTP not only offers more space, better working conditions for the team and access to university resources, but moving from suburban Chicago into the city also improves Sword’s ability to attract top talent with its metropolitan location – all key factors in our continued growth.

"The UTP lease allows us to expand into adjacent suites as the need arises without prematurely incurring costs. Wexford’s flexibility and willingness to partner with its tenants is critically important to high growth-stage companies like Sword Diagnostics.”

"Sword is a great example of the type of life science company that the Technology Business Center within UTP is designed for and dedicated to supporting,” said Catherine E. Vorwald, director of business development for Wexford Science + Technology, LLC. "UTP and IIT are able to offer Sword the resources, expertise, and environment it will need to grow and expand for many years to come. We are proud to add Sword to our growing roster of UTP tenants.”

Sword Diagnostics, Therapeutic Proteins, Chromatin, and Wrightwood Technologies will be among the UTP tenants who will participate in the Association of University Park’s (AURP) BioParks 2010 tour and reception at IIT on May 1. For more information on the two-day program, visit www.aurp.net/bioparks2010.

About Sword Diagnostics

Sword Diagnostics is a life sciences company committed to improving healthcare through the use of innovative detection technology. Selling to research facilities in pharmaceutical companies, academia and government, Sword helps its customers develop more sensitive biomarker tests without increasing cost or complexity. Sword’s patented biological detection technology accelerates the identification of existing and emerging disease markers, making researchers’ dream of early disease detection a reality. For more information, visit http://www.sworddiagnostics.com.

About University Technology Park at IIT (UTP)
The University Technology Park at IIT (UTP) is home to more than 20 emerging
technology-based companies and the Illinois Institute of Technology’s Pritzker Institute for Biomedical Science + Engineering. Launched in 2006, UTP's mission is to move innovation forward by providing quality flexible lab and office space for technology companies at every stage of their growth, and by offering tenants the resources of IIT and the community. The park's four-building complex includes the Technology Business Center (TBC), a technology incubator, a 19-story office tower, and the IIT Research Institute. For more information, visit http://www.universitytechnologypark.com.

About Wexford Science & Technology, LLC
Wexford Science & Technology, LLC (www.wexfordequities.com) is a privately held real estate investment and development company that delivers the real estate solution for science, technology, and healthcare based organizations. Headquartered in Baltimore, Wexford Science & Technology has projects in the contiguous United States with the University of Maryland, Baltimore, The Science Center (Philadelphia), Illinois Institute of Technology, Old Dominion University, the Hershey Center for Applied Research (Hershey Trust) , the University of Miami, and Wake Forest University.

For more information, contact:
Catherine E. Vorwald
Director, Business Development
Wexford Science + Technology, LLC
(443) 844-4172

Dave Dingott
President
Sword Diagnostics, Inc.
312-235-3661

# # #

Read the full story at http://www.prweb.com/releases/Sword/Diagnostics/prweb3927284.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Launch of NittoPhaseHL – High Loaded Solid Support for Oligonucleotide Synthesis
2. Caliper Life Sciences to Present at Deutsche Banks 35th Annual Health Care Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
4. NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology
5. Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders
6. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
7. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
8. Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications
9. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
10. YM BioSciences closes US$17.5 million financing
11. YM BioSciences to raise approximately US$15 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... , June 23, 2016 ... market research report to its pharmaceuticals section with ... product details and much more. Complete ... across 151 pages, profiling 15 companies and supported ... at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The ...
Breaking Biology Technology:
(Date:6/22/2016)... 2016 On Monday, the Department of Homeland ... share solutions for the Biometric Exit Program. The Request ... Protection (CBP), explains that CBP intends to add biometrics ... the United States , in order to deter ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
Breaking Biology News(10 mins):